Kobayashi H. Breathing nitric oxide plus hydrogen gas reduces ischemia-reperfusion injury and nitrotyrosine production in murine heart. Am J Physiol Heart Circ Physiol 305: H542-H550, 2013. First published June 14, 2013; doi:10.1152/ajpheart.00844.2012.-Inhaled nitric oxide (NO) has been reported to decrease the infarct size in cardiac ischemia-reperfusion (I/R) injury. However, reactive nitrogen species (RNS) produced by NO cause myocardial dysfunction and injury. Because H 2 is reported to eliminate peroxynitrite, it was expected to reduce the adverse effects of NO. In mice, left anterior descending coronary artery ligation for 60 min followed by reperfusion was performed with inhaled NO [80 parts per million (ppm)], H 2 (2%), or NO ϩ H2, starting 5 min before reperfusion for 35 min. After 24 h, left ventricular function, infarct size, and area at risk (AAR) were assessed. Oxidative stress associated with reactive oxygen species (ROS) was evaluated by staining for 8-hydroxy-2=-deoxyguanosine and 4-hydroxy-2-nonenal, that associated with RNS by staining for nitrotyrosine, and neutrophil infiltration by staining for granulocyte receptor-1. The infarct size/AAR decreased with breathing NO or H 2 alone. NO inhalation plus H2 reduced the infarct size/AAR, with significant interaction between the two, reducing ROS and neutrophil infiltration, and improved the cardiac function to normal levels. Although nitrotyrosine staining was prominent after NO inhalation alone, it was eliminated after breathing a mixture of H 2 with NO. Preconditioning with NO significantly reduced the infarct size/AAR, but not preconditioning with H 2. In conclusion, breathing NO ϩ H2 during I/R reduced the infarct size and maintained cardiac function, and reduced the generation of myocardial nitrotyrosine associated with NO inhalation. Administration of NO ϩ H 2 gases for inhalation may be useful for planned coronary interventions or for the treatment of I/R injury. nitric oxide; hydrogen gas; antioxidants; ischemia; reperfusion injury IT IS WELL-KNOWN THAT NITRIC oxide (NO) can produce both desirable and undesirable effects (25, 26) : NO has been reported to have both anti-inflammatory and cytocidal effects. The anti-inflammatory effects are presumably mediated by inhibition of platelet and neutrophil activation via enhanced guanylate cyclase (17) and/or poly (ADP-ribose) polymerase activity (3), and the cytocidal effects are presumably mediated by reactive nitrogen species (RNS), such as peroxynitrite generation (2), or from alternative pathways including nitrite/ H 2 O 2 /hemeperoxidase and transition metal-dependent mechanisms (20).
generation (2) , or from alternative pathways including nitrite/ H 2 O 2 /hemeperoxidase and transition metal-dependent mechanisms (20) .
Tyrosine nitration caused by RNS or the alternative pathways increases the activity of cytochrome C, fibrinogen, and protein kinase Cε and decreases the activity of mitochondrial manganese superoxide dismutase, prostacyclin synthase, actin (20) , and hemoxygenase (12) . It might have desirable effects in some specific situations (5) , but the reactions of RNS or the alternative pathways are strong and uncontrollable and may cause cellular malfunction, necrosis, or apoptosis (2, 5) , resulting in organ failure.
Inhaled NO has recently been reported to produce a wide range of extrapulmonary effects, such as inhibition of platelet and neutrophil activation, vasodilatation in ischemic tissues, and so on (6, 15) . Guery et al. (8) then demonstrated that pretreatment with inhaled 10 parts per million (ppm) NO improved cardiac function after ischemia-reperfusion (I/R), and Hataishi et al. (9) reported that inhaled NO decreased infarct size in mice subjected to cardiac ischemia followed by reperfusion. They noted that NO inhalation of 40 or 80 ppm, but not 20 ppm, decreased infarct size and improved the cardiac function. In the pig, inhaled 80 ppm NO was reported to decrease infarct size and improve cardiac function after myocardial I/R (13). These reports indicated the possible clinical usefulness of NO inhalation during coronary intervention, and a phase 2 randomized clinical trial is now under way: Effects of NO for inhalation in myocardial infarction size (NOMI), registered as NCT01398384 on July 18, 2011 (refer to http://clinicaltrials.gov/ct2/show/NCT01398384).
In 2008 Ohsawa et al. (19) reported that hydrogen gas (H 2 ) has the potential to act as an antioxidant. In their study, it was shown that H 2 selectively reduced the generation of hydroxyl radicals and peroxynitrite, thereby protecting the cells against oxidant injury. Furthermore, they studied an acute rat model in which oxidative stress was induced in the brain by focal I/R, and inhaled H 2 gas markedly suppressed the associated brain injury. Thus it was suggested that administration of H 2 by inhalation may serve as an effective therapy for I/R, and based on the ability of H 2 gas to rapidly diffuse across membranes, it can even protect ischemic tissues against oxidative damage. Hayashida et al. (10) investigated whether inhaled H 2 gas conferred cardioprotection against myocardial I/R injury in rats, and in an in vivo study, they observed that inhaled H 2 gas was rapidly transported to at-risk ischemic myocardium before coronary blood flow was reestablished in the occluded region. In the dogs, inhaled 1.3% H 2 gas was also reported to decrease infarct size after myocardial I/R (30). These reports indicated the possible clinical usefulness of H 2 inhalation during coronary intervention, and a randomized clinical trial is now in preparation for recruiting: The safety and efficacy of inhalation of H 2 gas during PCI in patients with acute myocardial infarction, registered as UMIN000006825 on December 4, 2011.
From these previous reports, we hypothesized that the inhibitory effect of NO on inflammation may be enhanced by eliminating highly reactive by-products of NO inhalation, such as peroxynitrite, by adding H 2 gas to inhaled NO gas. NO exerts potent inhibitory effects on platelets and neutrophils via activation of guanylate cyclase and is expected to dilate small blood vessels, particularly in ischemic tissues.
The aim of the present study was to determine whether inhalation of NO combined with H 2 gas might be more effective at reducing infarct size and improving heart function in a murine model of myocardial I/R in comparison with inhalation of NO or H 2 alone.
Our findings indicate that breathing NO plus H 2 can reduce cardiac injury and augment recovery of the left ventricular function, by elimination of the nitrotyrosine produced by NO inhalation alone, and suggest the potential usefulness of using a mixture of NO plus H 2 gases for inhalation during planned coronary interventions or for the treatment of I/R injury.
MATERIALS AND METHODS
Experimental procedures. The animal experimental protocol was approved by the Animal Research Committee of Kitasato University School of Allied Health Sciences as well as of Medicine and conformed to the Guide for the Care and Use of Laboratory Animals provided by the Institute for Laboratory Animal Research (National Research Council; National Academies Press) in 2011; the animal facility met the standards of the American Association for Accreditation of Laboratory Animal Care.
Ten-wk-old male C57BL/6J mice (body weight, 20 -25 g; CLEA Japan, Tokyo, Japan) were anesthetized by intraperitoneal administration of pentobarbital (60 mg/kg) and ventilated (MiniVent, Hugo Sachs Elektronik; Harvard Apparatus, Holliston, MA) at 0.2 FIo 2 ( Fig. 1) . After thoracotomy, myocardial ischemia was induced by ligation of the left coronary artery at the level of the left atrial appendage for 60 min at 0.3 FIo 2, followed by reperfusion for 24 h. From 5 min before reperfusion to 30 min after reperfusion, 2% H 2, 80 ppm NO, or a mixture of NO (80 ppm, 0.008%) and H 2 (2%) was administered by inhalation. The thorax was then closed in layers, and animals were allowed to recover from anesthesia. Ventilation at 0.3 FIo 2 was continued until the mice were awake. After the ventilator and extubation of the trachea were disconneted, mice were transferred into clean cages with free access to food and water.
NO was given at a concentration of 80 ppm, based upon a previous study on the cardioprotective effect of NO after myocardial I/R injury in mice, where NO inhalation of 40 or 80 ppm, but not 20 ppm, decreased infarct size and improved the cardiac function (9) . H2 was given at a concentration of 2%, based upon our dose-response experiment, where we confirmed that inhalation of 2% H2 reduced murine myocardial I/R injury and that the effect did not significantly differ from the effect of breathing 3% H 2 (see RESULTS shown below).
Previous studies have also reported that 2% H 2 inhalation was effective against I/R injury of the brain (19) , liver (7), and heart (10) in rats; furthermore, it was confirmed that the H 2 levels in the blood and myocardium changed within a few minutes of starting and discontinuing 2% H 2 inhalation, and H2 at a concentration of less than 4% in air is neither flammable nor combustible (1) .
In an attempt to eliminate the variable effects of H 2 produced by the natural enterobacterial flora, animals were administered antibiotics for 4 days by mixing penicillin (1.25 mg/ml) and streptomycin (2 mg/ml) in the drinking water and were denied access to food for 18 h before the surgery, and mice not treated with the antibiotics and with free food access were also studied as a control. To exclude the possible effects of antibiotics themselves on the infarct size after I/R, the antibiotics were injected intramuscularly just before the I/R experiments, and ratios of area at risk (AAR) to the total area of the left ventricle (LV) and the infarct size to AAR (infarct size/AAR) were observed. Fig. 1 . Experimental procedure. Myocardial ischemia was induced by transient occlusion of the left anterior descending coronary artery. After 60 min of ischemia, the coronary artery was reperfused and the thorax was closed. Beginning 5 min before reperfusion, 2% H2, 80 ppm (ϭ0.008%) nitric oxide (NO), or 80 ppm NO and 2% H2 (2%) was added to inspiratory gas at FIO2 0.3 exposure from 5 min before reperfusion and during the initial 30 min of reperfusion. The mouse was euthanized, and the heart was harvested and evaluated 24 h after reperfusion.
without treatment of antibiotics and fasting was examined in reference to the AAR.
Measurement of H 2 concentration in the expired air of mice. Before surgery, expired H2 concentrations were measured with an H2 sensor (XP-3160; New Cosmos Electric, Osaka, Japan). Expired air of mice was forced to flow at 50 ml/min for 10 min into a gas-tight sampling bag made of aluminum. The expired air in the bag was then introduced into the H 2 sensor (Fig. 2A) . We confirmed that the H2 concentration in the expired air of antibiotics-treated mice was below the 1-ppm detection limit, whereas it was well over the detection limit in all of the antibiotics nontreated mice (Fig. 2B) .
Echocardiography. Transthoracic echocardiography was performed with a commercially available echocardiography system (ProSound SDD-4000; ALOKA, Tokyo, Japan), using a 4 -14 MHz linear-array transducer. Closed-chest echocardiograms were obtained under anesthesia before the surgery and 24 h after reperfusion. The left ventricular ejection fraction (LVEF) was calculated using Mmode echocardiography.
Measurement of myocardial infarct size. At 24 h after reperfusion, the left coronary artery was religated, and a tissue-marking dye (Evans blue; Wako Pure Chemical, Tokyo, Japan) was injected through the inferior vena cava to determine the AAR. After the heart was harvested and placed in an agarose-containing well, the heart was sliced into 6 to 7 transverse slices of 1-mm thickness. The slices were placed in 1% 2,3,5-triphenyltetrazolium chloride solution in PBS for 10 min (first stain) and for 5 min (second stain), then washed with PBS for 5 min and fixed with formalin for 10 min. The infarct zone remained pale yellow, whereas the viable areas stained deep red. Digital images of the slices were obtained. The area stained with neither Evans blue (AAR) nor 2,3,5-triphenyltetrazolium chloride (infarct size) was measured on each slice image using an image software (ImageJ; National Institutes of Health) and summed. Ratios of AAR to the total area of the LV and the infarct size to AAR (infarct size/AAR) were calculated.
Immunohistochemical staining. Immunohistochemical staining of the heart tissues for 8-hydroxy-2=-deoxyguanosine (8-OHdG), 4-hydroxy-2-nonenal (4HNE), and nitrotyrosine and staining for granulocyte receptor-1 (Gr-1) of the neutrophils in the heart at 24 h after reperfusion were carried out (8-OHdG, 4HNE, and nitrotyrosine stainings at the Biopathology Institute, Oita, Japan; Gr-1 staining at Applied Medical Research Laboratory, Osaka, Japan) with randomized ID numbers, to ensure that the institute technicians were blind to the treatment allocation. Each harvested heart was fixed in Bouin's solution (picric acid-saturated solution:formalin:acetic acid ϭ 15:5:1) for 3 days. Paraffin sections were prepared using a Young-type sliding microtome (Sakura Finetek Japan) with a disposable microtome blade. The sections were 4 m thick and mounted on silane-coated slides and deparaffinized with xylene, followed by stepwise changes of the ethanol concentration.
The slides for 8-OHdG, 4HNE, and nitrotyrosine staining were treated with 1% hydrogen peroxide/methanol for 30 min to block endogenous peroxidase activity and rinsed in Tris-buffered saline. They were next treated with 8% skim milk for 30 min. Anti-8-OHdG monoclonal antibody, anti-4HNE monoclonal antibody (each diluted 1:50; Japan Institute for the Control of Aging, Nikken Seil, JaICA Japan), and anti-nitrotyrosine polyclonal antibody (diluted 1:200; 5 g/ml diluted in PBS containing 1% BSA; Millipore) in Tris-buffered saline were applied overnight to the sections in a moisture chamber at 4°C. They were then incubated in streptavidin-biotin-peroxidase solution according to the instructions for the strept ABComplex/HRP kit (Dako Japan) for 8-OHdG and 4HNE staining or according to the instructions for the MAX-PO kit (NICHIREI, Japan) for nitrotyrosine staining. The immunoreaction was visualized by the 3,3-diaminobenzidine (DAB) reaction for 8-OHdG and 4HNE and 3-amino-9-ethylcarbazole (AEC) for nitrotyrosine. The sections were counterstained with hematoxylin.
The slides for Gr-1 were treated with 3% hydrogen peroxide for 10 min to block endogenous peroxidase activity and rinsed in distilled water and Tris-buffered saline containing Tween 20. They were next treated with blocking solution containing 0.25% casein in PBS, stabilizing protein, and 0.015 mol/l sodium azide (X0909; Dako Japan) for 5 min. Anti-mouse Gr-1 rat monoclonal antibody (diluted 1:200; MAB1037; R&D Systems, Minneapolis, MN) was applied to the sections overnight in a moisture chamber at 4°C. The slides were then incubated using the MAX-PO kit (NICHIREI, Japan) for 30 min. The immunoreaction was visualized by the DAB reaction, and the sections were counterstained with hematoxylin.
8-OHdG staining was quantified by counting the stained nuclei (brown) and all nuclei (blue and brown) in five fields (240 ϫ 320 m) in each section for each animal (total of 3 animals). 4HNE and nitrotyrosine stainings were quantified by the ImageJ 1.40 g software. Brown color (the color of DAB staining) for 4HNE and red color (the color of AEC staining) for nitrotyrosine were extracted in five fields (50 ϫ 50 m) in each section for each animal (total of 3 animals), and the stained pixel numbers were calculated. The Gr-1 staining was quantified by counting the stained cells (brown) in two fields (1.9 ϫ 1.4 mm) in each section for each animal (total of 3 animals).
Preconditioning effect with either NO or H2 breathing. To investigate the preconditioning effect with either NO or H2 breathing on the infarct size, we placed anesthetized mice before the conventional 60-min occlusion of the left anterior coronary artery 1) with no preconditioning maneuver as a control, 2) under three times 5-min occlusion (ischemic preconditioning) in 5-min intervals, and 3) under Fig. 2 . Measurement of H2 concentration in the expired air of mice. A: mice were placed in a cage of 500 ml. Expired air of mice was forced to flow at 50 ml/min into a sampling bag for 10 min. B: concentration of H2 in expired air of mice, which were given antibiotics and were treated with fasting, decreased under the limit of detection. three times 5-min exposure to 2% H2 or 80 ppm NO (Fig. 7A) . In all the procedure FIo2 was fixed at 0.3.
Statistics. All data are presented as means ϩ SD. A one-way ANOVA with Tukey's post hoc test was used for multiple-group comparisons for all groups. A two-way ANOVA with replication was also used for comparison among the control (antibiotics ϩ), NO, H 2, and NO plus H 2 groups to determine the two-factor interaction between the effects of NO and H 2. Additionally, a paired t-test was used to compare the results of echocardiography for mice between before and after I/R.
RESULTS

Dose
response curve of breathing H 2 gas concentration and infarct size. Inhalation of 1% and 2% H 2 reduced murine myocardial I/R injury size, and the effects did not significantly differ from the effect of breathing 3% H 2 (Fig. 3) , as was reported in rats (10) . Inhaled NO and/or H 2 decreased the infarct size after I/R injury. The ratio of AAR to LV did not differ among groups (data not shown). The infarct size/AAR was significantly higher in mice administered antibiotics. Breathing NO, H 2 , or NO plus H 2 significantly decreased the infarct size/AAR. Furthermore, the infarct size/AAR in the mice that inhaled NO plus H 2 was significantly lower than that in those that inhaled NO alone (Fig. 4, A and B) , whereas the antibiotics intramuscular injection just before the I/R experiments did not show worsening in the infarct size (Fig. 4C) , with the same AARto-LV ratio (data not shown), indicating no direct protective effect of antibiotics on the cardiac I/R injury. The interaction between NO and H 2 was significant (P ϭ 0.0052).
The effects of the inhaled gases on the LVEF. Movement of the cardiac anterior wall of control mice was reduced after I/R, but that of mice inhaling NO plus H 2 remained unchanged (Fig. 4, D and E) . The LVEF after I/R in mice breathing NO plus H 2 was significantly improved as compared with that of control mice (Fig. 4E) . The interaction between NO and H 2 was not significant (P ϭ 0.4467).
Immunohistochemical staining with antibodies against 8-OHdG. In Fig. 5, A and B, the number of nuclei, calculated as a percentage of the total number of nuclei, that showed positive staining for 8-OHdG was significantly decreased in mice that breathed NO, H 2 , or NO plus H 2 as compared with that in the control mice. The number of positively stained nuclei in the mice that inhaled H 2 was significantly less than the value in mice that inhaled NO alone, but was not significantly different in mice inhaling NO plus H 2 . The interaction between NO and H 2 was significant (P Ͻ 0.0001).
Immunohistochemical staining with antibodies against 4HNE. Intense staining of the entire area for 4HNE was observed in the control groups (Fig. 5C ). In the NO inhalation group, the stained area was reduced, and no staining was observed in the H 2 inhalation group or the NO plus H 2 inhalation group (Fig.  5, D and E) . The interaction between NO and H 2 was significant (P ϭ 0.0006).
Nitrotyrosine formation in the heart tissue. The nitrotyrosine-stained area expressed as a percentage of the total area in the region of interest was large in the control (both antibiotics -and ϩ) groups and prominent in the NO inhalation group, whereas in the mice breathing NO plus H 2 the nitrotyrosine staining was absent (Fig. 6, A-C) . The interaction between NO and H 2 was significant (P Ͻ 0.0001).
Neutrophil infiltration in the heart tissue. The number of neutrophils in the region of interest in the slice was significantly decreased in the mice that inhaled NO or NO plus H 2 as compared with that in the control animals (ϩ) (Fig. 6, D and  E) . The interaction between NO and H 2 was significant (P ϭ 0.0225).
Preconditioning effect with either NO or H 2 breathing. As was observed and reported as the ischemic preconditioning effect before myocardial I/R, preconditioning with NO breathing before the 60-min occlusion also had effects in decreasing the infarct size, whereas H 2 breathing did not decrease the infarct size (Fig. 7B ).
DISCUSSION
The new findings after murine myocardial I/R in this study include 1) enterobacterial flora-derived H 2 slightly but significantly reduced myocardial infarct size; 2) NO plus H 2 breathing completely prevented the reduction of LVEF after I/R; 3) either NO or H 2 breathing alone decreased infarct size. The reduction of infarct size was significantly greater in mice that inhaled NO plus H 2 than in those breathing NO alone; 4) staining for reactive oxygen species (ROS) markers and neutrophils was reduced after NO and/or H 2 inhalation; 5) NO inhalation enlarged the myocardial staining area for nitrotyrosine, whereas H 2 inhalation completely eliminated the staining for nitrotyrosine; 6) preconditioning with NO before I/R decreased the infarct area, whereas preconditioning with H 2 did not.; and 7) repetitive two-way ANOVA revealed a significant interaction between the effects of NO and H 2 on the infarct size, ROS and nitrotyrosine production, and neutrophil infiltration.
The finding that the presence of enterobacterial flora caused a slight but significant reduction in infarct size suggests loss of H 2 -producing enterobacteria is a risk factor for massive infarction after I/R in the heart, and possibly in the brain, and may be clinically significant. It has also been reported in humans that the composition of the gut flora varies among individuals (21) Fig. 4 . Effects of the inhaled gas species on infarct size and heart function. A: representative cross sections after triphenyltetrazolium chloride staining in each group. B: ratio of infarct size to AAR (infarct size/AAR) was significantly larger in mice given antibiotics. Breathing NO, H2, and NO plus H2 significantly decreased the infarct size/AAR. The infarct size/AAR in mice that inhaled NO plus H2 was significantly lower than that of the mice that breathed NO only. C: to exclude the possible direct protective effects of antibiotics on the infarct size after I/R, the antibiotics were given per os (p.o.) as in the protocol (Fig.1) or injected intramuscularly (i.m.) just before the I/R experiments, and no worsening in the infarct size by intramuscular injection has been observed, indicating no direct effect of antibiotics on the infarct size. D: typical echocardiographic image at 24 h after I/R. E: LV ejection fraction (LVEF) of mice before and at 24 h after I/R. LVEF was significantly decreased at 24 h after I/R, except in mice that inhaled NO plus H2. LVEF after I/R in the mice inhaling NO plus H2 was significantly improved compared with that in the control mice. Data are presented as means ϩ SD. NS, not significant. Fig. 5 . Immunohistochemical staining for 8-hydroxy-2=-deoxyguanosine and 4-hydroxy-2-nonenal (4HNE). A: nuclei stained blue with hematoxylin and stained brown by the 3,3-diaminobenzidine (DAB) reaction using primary antibody against 8-hydroxy-2=-deoxyguanosine. B: number of 8-hydroxy-2=-deoxyguanosineimmunoreactive nuclei, expressed as a percentage of the total number of nuclei in the region of interest in the slice, was significantly decreased in the mice that inhaled NO, H2, or NO plus H2. C: nuclei stained blue with hematoxylin and cells stained brown by the DAB reaction using antibody against 4HNE. D: histogram of the brown color of each image extracted by color deconvolution. The tone level of the brown color component of each pixel was presented on a scale of 0 (brown) to 255 (white). E: 4HNE-immunoreactive area was expressed as a percentage of the total area in the region of interest of the slice. Intense staining for 4HNE was observed in the entire infarct area in control groups. Inhalation of NO reduced the stained area as compared with that of control group. The stained area was eliminated in both the H2 group and the H2 plus NO group. Data are presented as means ϩ SD. . C: nitrotyrosine-immunoreactive area (number of pixels of red color) was expressed as a percentage of the total area covered by the cells (number of pixels covered by the cells) in each section. The nitrotyrosineimmunoreactive area was significantly larger in the NO group than in other groups. Nitrotyrosine immunostaining was completely absent in both the H2 group and NO plus H2 groups. D: neutrophils stained brown by the DAB reaction after incubation with a primary antibody against granulocyte receptor-1, and the nuclei stained blue with hematoxylin. E: number of neutrophils in the region of interest in the slice was significantly decreased in the mice that inhaled NO or NO plus H2 as compared with that in the control animals (ϩ). Data are presented as means ϩ SD. from H 2 -dominant production to methane dominant. A number of probiotic supplements are reported to be cardioprotective, while their effect may not be related to H 2 production; on the other hand, the cardioprotective effect of dietary fiber (23) may be related to H 2 production. Poorly digestible fiber debris is transported to the distal intestine, where anaerobes ferment the debris, and produce not only H 2 , but also methane, hydrogen sulfide, and so on. Therefore, it cannot be excluded that antibiotics also eliminated other potential cardioprotective gases. It would be interesting to study the specific protective effect of H 2 by inoculating wild-type bacteria producing H 2 and gene-manipulated bacteria unable to produce H 2 after clearing the enteric bacteria, similar to the strategy used for demonstrating the protective role of H 2 -producing Escherichia coli against Concanavalin A-induced hepatitis (11) .
Although the persistent but low-dose production of H 2 by enteric bacteria may contribute to reduction in the infarct size, or the dose-response relation for H 2 on the infarct size may be very steep, it should be noted that enterobacterial flora-derived gases were not sufficiently potent for cardioprotection after I/R injury, since inhalation of H 2 even in the presence of enterobacterial flora significantly reduced the infarct size (Fig. 3) . Nagasaka et al. (18) have shown that the cardioprotective effects of inhaled NO require the presence of soluble guanylate cyclase-␣ 1 , and the results of their study suggested that bone marrow-derived cells are mediators of the ability of NO to attenuate cardiac I/R injury. Therefore, it is possible that a primary role of NO is to inhibit recruitment of leukocytes from blood stream to the heart. Their finding of the local effect of NO during myocardical I/R injury is in line with our finding of reduced neutrophil infiltration observed following NO inhalation, as well as of the in vivo preconditioning cardioprotective effect of NO breathing before the induction of I/R injury on the infarct size.
Ohsawa et al. (19) showed in an in vitro study that H 2 gas can reduce hydroxyl radicals. However, the reaction of H 2 with hydroxyl radicals is controversial. Because the half-life of hydroxyl radicals is short, 10 Ϫ9 s (24), Wood and Gladwin (29) noted that the hydroxyl radical is too short-lived to react with H 2 , and will react with several cellular components before reacting with less abundant H 2 molecules. As compared with that of hydroxyl radicals, the half-life of peroxynitrite is long, 0.05-1 s (24) , and peroxynitrite has a greater chance to react with H 2 in areas of I/R injury. H 2 molecules are very diffusible and may reach ischemic tissues even before reperfusion (10) . During I/R, they will eliminate peroxynitrite (and possibly hydroxyl radicals), thereby suppressing inflammation and cellular apoptosis. Concerning the mechanism of the effects of H 2 gas, other possible sites of action of H 2 have been suggested, such as induction of hemoxygenase 1 (4) and heat shock protein (28) . These possibilities need to be further investigated.
A comparison of the effects of inhaled NO with those of inhaled H 2 in our study revealed that they exerted equivalent cardioprotective effect, both in terms of improving the cardiac function and reducing the infarct size. The ROS markers, 8-OHdG and 4HNE, were similarly eliminated. A major difference between the effects of NO and H 2 breathing is the production of nitrotyrosine in the tissue affected by I/R injury in NO breathing. The increased amount of nitrotyrosine produced by inhaled NO suggests that some adverse effects on signal trafficking and cellular function may occur sooner or later by the RNS reactions with the tyrosine at the active site of vital enzymes and cellular components.
It should be noted that we used the maximal concentration of NO, 80 ppm, as had been reported to be effective in the protection of heart against I/R injury. Furthermore, we placed the mice under the minimal contribution of enterobacterial flora-derived H 2 by administrating antibiotics with fasting. It is possible that less NO inhalation with more enterobacterial flora-derived H 2 might potently protect the heart from I/R injury, but even in that case H 2 inhalation would minimize the potential risk caused by nitrotyrosine production.
Other potential methods to reduce peroxynitrite production while maintaining the beneficial effects of inhaled NO could be to use a peroxynitrite decomposition catalyst (14, 27) or increase the cGMP concentration in the cells by using a soluble guanylyl cyclase activator (22) or phosphodiesterase-5 inhibitor (16) , since these enhancers of NO effects via cGMP induction may enable reduction of the inhaled NO concentration, thereby decreasing peroxynitrite formation and minimizing the adverse effects of NO inhalation.
One of the limitations of this in vivo study was that young male mice were used for this study, whereas myocardial I/R injury typically occurs in older individuals with comorbid risk factors such as diabetes and atherosclerosis; furthermore, many cardioprotective interventions that are effective in younger animals are not effective in older animals or in the presence of risk factors, a phenomenon that may be related to chronic oxidative stress (31) . Therefore, it will be important to verify our study findings in older mice and in relation to enterobacterial flora-derived H 2 .
In conclusion, inhaled NO suppresses the inflammation in I/R tissues and H 2 eliminates the adverse by-products of NO exposure, peroxynitrite. Thus our study supports the view that NO and H 2 are suggestive partners that can be used as a mixture for breathing during coronary interventions.
